Package 66298-5340-1

{"route": ["INTRAVENOUS"], "spl_id": "2bafe5a8-0ec4-b2c9-e063-6294a90a2d5f", "openfda": {"nui": ["N0000175634", "N0000175632"], "unii": ["6T84R30KC1"], "rxcui": ["2170286"], "spl_set_id": ["0c638812-ba60-49fe-a715-f40246b6cbf7"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["HP Halden Pharma AS"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BAG in 1 CASE (66298-5340-1)  / 100 mL in 1 BAG", "package_ndc": "66298-5340-1", "marketing_start_date": "20241210"}], "brand_name": "Tranexamic Acid in Sodium Chloride", "product_id": "66298-5340_2bafe5a8-0ec4-b2c9-e063-6294a90a2d5f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "66298-5340", "generic_name": "TRANEXAMIC ACID", "labeler_name": "HP Halden Pharma AS", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tranexamic Acid in Sodium Chloride", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "10 mg/mL"}], "application_number": "ANDA218242", "marketing_category": "ANDA", "marketing_start_date": "20241210", "listing_expiration_date": "20261231"}